Effectiveness of 7-day triple therapy with half-dose clarithromycin for the eradication of Helicobacter pylori without the A2143G and A2142G point mutations of the 23S rRNA gene in a high clarithromycin resistance area
BackgroundTailored therapy has been widely used for patients with Helicobacter pylori (H. pylori) infection in South Korea. Herein, we evaluated the treatment outcomes of tailored clarithromycin-based triple therapy (TT) in patients infected with H. pylori.MethodsWe enrolled 460 patients without A21...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-03-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2023.1150396/full |
| _version_ | 1827985730224259072 |
|---|---|
| author | Seong Hyun Cho Moon Sik Park Seon-Young Park Dong Hyun Kim Hye-Su You Hyun-Soo Kim |
| author_facet | Seong Hyun Cho Moon Sik Park Seon-Young Park Dong Hyun Kim Hye-Su You Hyun-Soo Kim |
| author_sort | Seong Hyun Cho |
| collection | DOAJ |
| description | BackgroundTailored therapy has been widely used for patients with Helicobacter pylori (H. pylori) infection in South Korea. Herein, we evaluated the treatment outcomes of tailored clarithromycin-based triple therapy (TT) in patients infected with H. pylori.MethodsWe enrolled 460 patients without A2142G and A2143G point mutations by dual priming oligonucleotide-based polymerase chain reaction who had taken TT and undergone the urease breath test to evaluate eradication in clinical practice. Eradication rates according to the treatment duration and dose of clarithromycin were analyzed.ResultsAmong 460 patients (164 women, median age 63.0 years), 250 patients underwent TT with full-dose clarithromycin (TT-full CLA), and 216 patients underwent TT with half-dose clarithromycin (TT-half CLA). The eradication rates were 88.0% (220/250) in patients with TT-full CLA and 85.2% (179/210) in patients with TT-half CLA. In 250 patients with TT-full CLA, the eradication rates were 86.8% (33/38) in patients with 7-day TT-full CLA and 88.2% (187/212) in patients with 10-day or 14-day TT-full CLA (P = 0.788). In 210 patients with TT-half CLA, the eradication rates were 84.2% (139/165) in those with a 7-day TT-half CLA and 88.9% (40/45) in those with a 10-day or 14-day TT-half CLA (P = 0.436).ConclusionFor patients with H. pylori infection without A2142G and A2143G point mutations by DPO-PCR in clinical practice, treatment extension above 7-day TT with full CLA did not improve the eradication rates. Future studies on the treatment outcomes of TT-half CLA considering effectiveness and compliance are warranted. |
| first_indexed | 2024-04-09T23:19:04Z |
| format | Article |
| id | doaj.art-e6db05b0eb774c6dad1960a11d4fef55 |
| institution | Directory Open Access Journal |
| issn | 2296-858X |
| language | English |
| last_indexed | 2024-04-09T23:19:04Z |
| publishDate | 2023-03-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Medicine |
| spelling | doaj.art-e6db05b0eb774c6dad1960a11d4fef552023-03-22T04:40:56ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2023-03-011010.3389/fmed.2023.11503961150396Effectiveness of 7-day triple therapy with half-dose clarithromycin for the eradication of Helicobacter pylori without the A2143G and A2142G point mutations of the 23S rRNA gene in a high clarithromycin resistance areaSeong Hyun ChoMoon Sik ParkSeon-Young ParkDong Hyun KimHye-Su YouHyun-Soo KimBackgroundTailored therapy has been widely used for patients with Helicobacter pylori (H. pylori) infection in South Korea. Herein, we evaluated the treatment outcomes of tailored clarithromycin-based triple therapy (TT) in patients infected with H. pylori.MethodsWe enrolled 460 patients without A2142G and A2143G point mutations by dual priming oligonucleotide-based polymerase chain reaction who had taken TT and undergone the urease breath test to evaluate eradication in clinical practice. Eradication rates according to the treatment duration and dose of clarithromycin were analyzed.ResultsAmong 460 patients (164 women, median age 63.0 years), 250 patients underwent TT with full-dose clarithromycin (TT-full CLA), and 216 patients underwent TT with half-dose clarithromycin (TT-half CLA). The eradication rates were 88.0% (220/250) in patients with TT-full CLA and 85.2% (179/210) in patients with TT-half CLA. In 250 patients with TT-full CLA, the eradication rates were 86.8% (33/38) in patients with 7-day TT-full CLA and 88.2% (187/212) in patients with 10-day or 14-day TT-full CLA (P = 0.788). In 210 patients with TT-half CLA, the eradication rates were 84.2% (139/165) in those with a 7-day TT-half CLA and 88.9% (40/45) in those with a 10-day or 14-day TT-half CLA (P = 0.436).ConclusionFor patients with H. pylori infection without A2142G and A2143G point mutations by DPO-PCR in clinical practice, treatment extension above 7-day TT with full CLA did not improve the eradication rates. Future studies on the treatment outcomes of TT-half CLA considering effectiveness and compliance are warranted.https://www.frontiersin.org/articles/10.3389/fmed.2023.1150396/fullHelicobacter pylorieradicationclarithromycinresistancepoint mutation |
| spellingShingle | Seong Hyun Cho Moon Sik Park Seon-Young Park Dong Hyun Kim Hye-Su You Hyun-Soo Kim Effectiveness of 7-day triple therapy with half-dose clarithromycin for the eradication of Helicobacter pylori without the A2143G and A2142G point mutations of the 23S rRNA gene in a high clarithromycin resistance area Frontiers in Medicine Helicobacter pylori eradication clarithromycin resistance point mutation |
| title | Effectiveness of 7-day triple therapy with half-dose clarithromycin for the eradication of Helicobacter pylori without the A2143G and A2142G point mutations of the 23S rRNA gene in a high clarithromycin resistance area |
| title_full | Effectiveness of 7-day triple therapy with half-dose clarithromycin for the eradication of Helicobacter pylori without the A2143G and A2142G point mutations of the 23S rRNA gene in a high clarithromycin resistance area |
| title_fullStr | Effectiveness of 7-day triple therapy with half-dose clarithromycin for the eradication of Helicobacter pylori without the A2143G and A2142G point mutations of the 23S rRNA gene in a high clarithromycin resistance area |
| title_full_unstemmed | Effectiveness of 7-day triple therapy with half-dose clarithromycin for the eradication of Helicobacter pylori without the A2143G and A2142G point mutations of the 23S rRNA gene in a high clarithromycin resistance area |
| title_short | Effectiveness of 7-day triple therapy with half-dose clarithromycin for the eradication of Helicobacter pylori without the A2143G and A2142G point mutations of the 23S rRNA gene in a high clarithromycin resistance area |
| title_sort | effectiveness of 7 day triple therapy with half dose clarithromycin for the eradication of helicobacter pylori without the a2143g and a2142g point mutations of the 23s rrna gene in a high clarithromycin resistance area |
| topic | Helicobacter pylori eradication clarithromycin resistance point mutation |
| url | https://www.frontiersin.org/articles/10.3389/fmed.2023.1150396/full |
| work_keys_str_mv | AT seonghyuncho effectivenessof7daytripletherapywithhalfdoseclarithromycinfortheeradicationofhelicobacterpyloriwithoutthea2143ganda2142gpointmutationsofthe23srrnageneinahighclarithromycinresistancearea AT moonsikpark effectivenessof7daytripletherapywithhalfdoseclarithromycinfortheeradicationofhelicobacterpyloriwithoutthea2143ganda2142gpointmutationsofthe23srrnageneinahighclarithromycinresistancearea AT seonyoungpark effectivenessof7daytripletherapywithhalfdoseclarithromycinfortheeradicationofhelicobacterpyloriwithoutthea2143ganda2142gpointmutationsofthe23srrnageneinahighclarithromycinresistancearea AT donghyunkim effectivenessof7daytripletherapywithhalfdoseclarithromycinfortheeradicationofhelicobacterpyloriwithoutthea2143ganda2142gpointmutationsofthe23srrnageneinahighclarithromycinresistancearea AT hyesuyou effectivenessof7daytripletherapywithhalfdoseclarithromycinfortheeradicationofhelicobacterpyloriwithoutthea2143ganda2142gpointmutationsofthe23srrnageneinahighclarithromycinresistancearea AT hyunsookim effectivenessof7daytripletherapywithhalfdoseclarithromycinfortheeradicationofhelicobacterpyloriwithoutthea2143ganda2142gpointmutationsofthe23srrnageneinahighclarithromycinresistancearea |